ArticleJournal of inflammation (London, England)2016

The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets.

Torsten Lowin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.